13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Progress in developing new therapies for bronchopulmonary dysplasia (BPD) is sometimes complicated by the lack of a standardised animal model. Our objective was to develop a robust hyperoxia-based mouse model of BPD that recapitulated the pathological perturbations to lung structure noted in infants with BPD. Newborn mouse pups were exposed to a varying fraction of oxygen in the inspired air (FiO 2) and a varying window of hyperoxia exposure, after which lung structure was assessed by design-based stereology with systemic uniform random sampling. The efficacy of a candidate therapeutic intervention using parenteral nutrition was evaluated to demonstrate the utility of the standardised BPD model for drug discovery. An FiO 2 of 0.85 for the first 14 days of life decreased total alveoli number and concomitantly increased alveolar septal wall thickness, which are two key histopathological characteristics of BPD. A reduction in FiO 2 to 0.60 or 0.40 also caused a decrease in the total alveoli number, but the septal wall thickness was not impacted. Neither a decreasing oxygen gradient (from FiO 2 0.85 to 0.21 over the first 14 days of life) nor an oscillation in FiO 2 (between 0.85 and 0.40 on a 24 h:24 h cycle) had an appreciable impact on lung development. The risk of missing beneficial effects of therapeutic interventions at FiO 2 0.85, using parenteral nutrition as an intervention in the model, was also noted, highlighting the utility of lower FiO 2 in selected studies, and underscoring the need to tailor the model employed to the experimental intervention. Thus, a state-of-the-art BPD animal model that recapitulates the two histopathological hallmark perturbations to lung architecture associated with BPD is described. The model presented here, where injurious stimuli have been systematically evaluated, provides a most promising approach for the development of new strategies to drive postnatal lung maturation in affected infants.

          Abstract

          Summary: A newborn mouse model of bronchopulmonary dysplasia in which oxygen injury is systematically standardised recapitulates the two pathological hallmarks of disease.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: not found

          The new bronchopulmonary dysplasia.

          Alan Jobe (2011)
          Bronchopulmonary dysplasia (BPD) remains the most common severe complication of preterm birth. A number of recent animal models and clinical studies provide new information about pathophysiology and treatment. The epidemiology of BPD continues to demonstrate that birth weight and gestational age are most predictive of BPD. Correlations of BPD with chorioamnionitis are clouded by the complexity of the fetal exposures to inflammation. Excessive oxygen use in preterm infants can increase the risk of BPD but low saturation targets may increase death. Numerous recent trials demonstrate that many preterm infants can be initially stabilized after delivery with continuous positive airway response (CPAP) and then be selectively treated with surfactant for respiratory distress syndrome. The growth of the lungs of the infant with BPD through childhood remains poorly characterized. Recent experiences in neonatology suggest that combining less invasive care strategies that avoid excessive oxygen and ventilation, decrease postnatal infections, and optimize nutrition may decrease the incidence and severity of BPD.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Animal models of bronchopulmonary dysplasia. The term mouse models.

            The etiology of bronchopulmonary dysplasia (BPD) is multifactorial, with genetics, ante- and postnatal sepsis, invasive mechanical ventilation, and exposure to hyperoxia being well described as contributing factors. Much of what is known about the pathogenesis of BPD is derived from animal models being exposed to the environmental factors noted above. This review will briefly cover the various mouse models of BPD, focusing mainly on the hyperoxia-induced lung injury models. We will also include hypoxia, hypoxia/hyperoxia, inflammation-induced, and transgenic models in room air. Attention to the stage of lung development at the timing of the initiation of the environmental insult and the duration of lung injury is critical to attempt to mimic the human disease pulmonary phenotype, both in the short term and in outcomes extending into childhood, adolescence, and adulthood. The various indexes of alveolar and vascular development as well as pulmonary function including pulmonary hypertension will be highlighted. The advantages (and limitations) of using such approaches will be discussed in the context of understanding the pathogenesis of and targeting therapeutic interventions to ameliorate human BPD.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia.

              The pathogenesis of bronchopulmonary dysplasia (BPD), a devastating lung disease in preterm infants, includes inflammation, the mechanisms of which are not fully characterized. Here we report that the activation of the NLRP3 inflammasome is associated with the development of BPD. Hyperoxia-exposed neonatal mice have increased caspase-1 activation, IL1β and inflammation, and decreased alveolarization. Nlrp3(-/-) mice have no caspase-1 activity, no IL1β, no inflammatory response and undergo normal alveolarization. Treatment of hyperoxia-exposed mice with either IL1 receptor antagonist to block IL1β or glyburide to block the Nlrp3 inflammasome results in decreased inflammation and increased alveolarization. Ventilated preterm baboons show activation of the NLRP3 inflammasome with increased IL1β:IL1ra ratio. The IL1β:IL1ra ratio in tracheal aspirates from preterm infants with respiratory failure is predictive of the development of BPD. We conclude that early activation of the NLRP3 inflammasome is a key mechanism in the development of BPD, and represents a novel therapeutic target for BPD.
                Bookmark

                Author and article information

                Journal
                Dis Model Mech
                Dis Model Mech
                DMM
                dmm
                Disease Models & Mechanisms
                The Company of Biologists Ltd
                1754-8403
                1754-8411
                1 February 2017
                1 February 2017
                : 10
                : 2
                : 185-196
                Affiliations
                [1 ]Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research , 61231 Bad Nauheim, Germany
                [2 ]Department of Internal Medicine (Pulmonology), University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL) , 35392 Giessen, Germany
                Author notes
                [* ]Author for correspondence ( rory.morty@ 123456mpi-bn.mpg.de )
                Author information
                http://orcid.org/0000-0003-0833-9749
                Article
                DMM027086
                10.1242/dmm.027086
                5312005
                28067624
                57603e46-6dda-45e9-92ad-7ccf51a0d38f
                © 2017. Published by The Company of Biologists Ltd

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

                History
                : 9 July 2016
                : 24 November 2016
                Funding
                Funded by: Max-Planck-Gesellschaft, http://dx.doi.org/10.13039/501100004189;
                Funded by: Rhön Klinikum AG;
                Award ID: Fl_66
                Funded by: Hessisches Ministerium für Wissenschaft und Kunst, http://dx.doi.org/10.13039/501100003495;
                Award ID: LOEWE
                Funded by: Deutsches Zentrum für Lungenforschung, http://dx.doi.org/10.13039/100009139;
                Award ID: 1789/1
                Funded by: Deutsche Forschungsgemeinschaft, http://dx.doi.org/10.13039/501100001659;
                Award ID: KFO309/1
                Award ID: EXC147
                Award ID: SFB1213/1
                Categories
                Resource Article

                Molecular medicine
                bpd,hyperoxia,alveolarisation,structure,animal model
                Molecular medicine
                bpd, hyperoxia, alveolarisation, structure, animal model

                Comments

                Comment on this article